Effects of Na+, k+, mg++ and Ca++ on the saturable binding of [3H]dihydromorphine and [3H]naloxone in vitro.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000494:pharmacology; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism; D004573:Electrolytes / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009022:Morphine Derivatives / Q000378:metabolism*; D009270:Naloxone / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013788:Thalamus / Q000187:drug effects / Q000378:metabolism
D004573:Electrolytes; D009022:Morphine Derivatives; D009270:Naloxone; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium